Opthea completes enrollment in two phase 3 trials of sozinibercept in wet AMD
Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The COAST and ShORe trials have enrolled a total of 1,984 …